FeesSafety
Pluang+

Altius Labs buys shares in edgeX to build global trading and liquidity tools.

Protocol Fundamentals
18 Nov 2026, 14:36 WIB
Tokenpost
View Source
Bullish
Altius Labs buys shares in edgeX to build global trading and liquidity tools.

Altius Labs has acquired shares in edgeX from Amber Group, becoming a strategic shareholder and planning to develop trading and liquidity infrastructure for exchanges and brokerages worldwide. Altius Labs CEO Annabelle Huang will join edgeX as a core contributor. edgeX, launched in October 2024, has served over 500,000 users with $1.1 trillion in trading volume and aims to expand beyond crypto into tokenized stocks, commodities, and forex. The partnership will create shared tools for onchain markets, improving order matching, trade clearing, and settlement while allowing partner platforms to maintain their brands and user bases.

Altius Labs' strategic move to acquire edgeX shares comes as a backdrop to a mixed cryptocurrency market on Pluang. For readers following major cryptocurrencies, here is Pluang's market snapshot as of Nov 18, 2026 19:32 WIB: out of 50 priced assets, 20 rose and 28 fell. Notable movers include EOS with a price of Rp12.649 and a 1-day change of +8.13%, BAT at Rp1.713 with a 1-day change of -5.70% and a Pluang order activity heavily skewed to selling at 99%, and SNX priced at Rp2.830 with a 1-day change of +5.44% and 100% buy order activity.

More News

Lowe's beats Q3 earnings estimates and raises full-year sales outlook.

Lowe's beats Q3 earnings estimates and raises full-year sales outlook.

Lowe's reported adjusted earnings per share of $3.10, surpassing estimates of $2.88, and revenue of $22.80 billion, beating the $22.40 billion forecast. Comparable sales rose 1.8%, driven by strong online and professional services sales. The company ...

Company Fundamentals
Bullish
49 minutes ago
Major Memphis health system expands Daxor's blood volume testing to new outpatient site with 24-hour results.

Major Memphis health system expands Daxor's blood volume testing to new outpatient site with 24-hour results.

Daxor Corporation announced that a major Memphis health system has expanded its Blood Volume Analysis (BVA) program to an additional hospital outpatient site using Daxor’s ezBVA Lab service. This expansion allows the outpatient clinic to receive bloo...

Market News
Bullish
54 minutes ago
Microsoft shares drop 2.27% after global outages despite Oppenheimer's Outperform rating

Microsoft shares drop 2.27% after global outages despite Oppenheimer's Outperform rating

Microsoft's stock fell 2.27% to $506.24 following global outages affecting its Copilot, Teams, and Outlook services. The outages, attributed to server issues rather than cyberattacks, raised concerns amid broader software sector weakness. Oppenheimer...

Market News
Bearish
1 hour ago
Target posts strongest sales growth in 5 years, raises annual sales growth target to 6%.

Target posts strongest sales growth in 5 years, raises annual sales growth target to 6%.

Target Corporation reported earnings per share of $2.65, beating estimates of $2.08, and revenue of $27.1 billion, surpassing the $26.5 billion forecast. The company achieved its strongest quarterly sales growth in about five years, with net sales up...

Company Fundamentals
Bullish
1 hour ago
Aquestive Therapeutics to present at Piper Sandler Healthcare Conference on Dec 2, 2026

Aquestive Therapeutics to present at Piper Sandler Healthcare Conference on Dec 2, 2026

Aquestive Therapeutics announced its participation in the Piper Sandler 38th Annual Healthcare Conference from December 1-3, 2026, in New York City. CEO Daniel Barber will present on December 2 at 10:30 am ET, with one-on-one investor meetings schedu...

Market News
Neutral
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App